
Map Shows States Where COVID Is Rising
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
COVID-19 cases are reported to be rising in 27 states and "likely growing" in 12 states more as well as in Washington D.C., according to the latest data from the U.S. Centers for Disease Control and Prevention (CDC).
The national health body warned that COVID-19 infections are estimated to be "growing or likely growing in 40 states [including D.C.], declining or likely declining in zero states, and not changing in nine states," as of July 29.
"COVID-19 activity is increasing in many Mid-Atlantic, Southeast, Southern, and West Coast states," the CDC said on August 1.
The percentage of positive cases is increasing nationally and while emergency department visits for COVID-19 are low, these visits are rising among all ages.
"The current rise in COVID-19 cases is likely multifactorial," Dr. Steven Goldberg, primary care/urgent care physician and chief medical officer at HealthTrackRx—a PCR testing company that works with the CDC to help create fast testing for viruses including COVID-19— told Newsweek.
He explained: "Increased summer travel, indoor gatherings due to high temperatures, waning vaccine immunity and the emergence of immune-evasive Omicron subvariants like KP.3 and LB.1 all play a role."
"Wastewater surveillance, along with anecdotal reports of increased COVID-19–related ER and urgent care visits, corroborate this increase," Goldberg said.
"Notably, real-time transmission estimates (Rt) show values above 1 in most states, indicating active spread."
(Rt—the "effective reproduction number"—is an estimate of the average number of new infections caused by each infectious person.)
The states with rising cases are each reported to have a more than 90 percent probability that the "COVID-19 epidemic is growing" there. The states with some of the highest probabilities include Florida (99.92 percent), Massachusetts (99.68 percent), Texas (99.52 percent) and Maryland (98.95 percent.)
While the current summer wave of cases is less severe than previous peaks, "this surge may intensify further in the fall with back-to-school and return-to-office patterns unless mitigated by vaccine uptake and public awareness," Goldberg warned.
The nine states where cases remain unchanged in recent days include Alaska, Hawaii, Idaho, Maine, Montana, Nevada, New Mexico, Rhode Island and Vermont. The percent of emergency department visits in these states was reported to be either low or very low, according to the CDC.
According to Goldberg, several factors may explain the plateau in these nine states, including lower population density, such as in Montana and Alaska, as well limited large-scale indoor gatherings, and higher vaccine booster uptake.
"It's also possible that regional Rt estimates are slightly lagging and may rise in future updates," he noted.
The physician says updated vaccines targeting the latest Omicron sublineages, which are expected to emerge in the fall this year, are "essential" for combating rising cases and new variants.
He said: "These next-generation vaccines are designed to enhance protection against immune-evasive strains like the Omicron-subvariants KP.3 and LB.1."
Goldberg says that while reinstating broad health mandates may not be necessary at this stage, "targeted recommendations are prudent," noting that supporting voluntary masking in healthcare settings, airports, and high-risk indoor gatherings can help reduce transmission. He advises encouraging vaccination, especially for people at high risk as well as those living with high-risk individuals.
Newsweek has contacted the CDC for comment via email and its online media contact form.
Do you have a tip on a health story that Newsweek should be covering? Do you have a question about COVID-19? Let us know via health@newsweek.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
CDC warns travelers about chikungunya cases in China as global infections hit 240,000
U.S. health officials are cautioning travelers about a mosquito-borne illness being transmitted in parts of Asia, South America, Africa and the Indian Ocean. Across the globe, the chikungunya virus has sparked 240,000 cases and 90 deaths in 2025, according to the European Centre for Disease Prevention and Control. The virus, which is infecting people through bites from Aedes mosquitoes, has been spreading in China's Guangdong province this summer. Health officials reported the area has seen over 7,000 confirmed cases since June. The U.S. Centers for Disease Control and Prevention (CDC) this month issued a travel notice for the Guangdon province in China, encouraging travelers to practice enhanced precautions. The agency issued the same notices for other countries where outbreaks have been reported, including Bolivia, Kenya, Madagascar, Mauritius, Mayotte, Réunion, Somalia and Sri Lanka. The CDC is also asking U.S. residents to exercise caution when visiting the following countries, which have not yet reported an outbreak but are at elevated risk of exposure: Brazil, Colombia, Mexico, India, Pakistan, Philippines, Thailand and Nigeria. According to the World Health Organization (WHO), 5.6 billion people are at risk of arboviral diseases such as chikungunya. Other widespread arboviruses impacting humans include dengue, Zika and yellow fever. What are the symptoms of chikungunya? Symptoms of the disease include fever, joint pain and swelling, headache, muscle pain and rash, according to the CDC. How long does infection last? The illness typically lasts between two to 12 days after infection. Some patients can experience extreme symptoms and the virus can be fatal. Elderly people, newborns and individuals with underlying medical conditions are at higher risk of medical intervention. Severe complications, including cardiovascular, neurological and multiorgan involvement, may require intensive medical care, according to the WHO. However, more than half of patients will experience symptoms commonly associated with a fever. What treatments are available? There are no known antiviral treatments for the illness. Medications can be used to manage pain and fever. Two chikungunya vaccines have received regulatory approval but are not widely available. In May, federal officials recommended pausing a vaccine in the United States after reports of serious adverse events. The illness was first discovered in Tanzania in 1952, with outbreaks being reported in Africa and Asia, according to the WHO. Since then, the virus has been transmitted to 119 countries. Last year, more than 620,000 and 213 deaths were reported globally, according to the European Centre for Disease Prevention and Control. In what was then dubbed the largest documented outbreak of chikungunya, an estimated several hundred thousand people were affected by "explosive" outbreaks of the virus in the Indian Ocean islands and India, according to a 2008 study. It's estimated that about 60 percent of regional populations were exposed. CDC issues travel notice for Americans The CDC issued a travel warning on Friday, Aug. 1, advising U.S. residents to take enhanced precautions when traveling to China. Most of the country's cases have been reported in the city of Foshan. Last month, Chinese officials held a national conference to discuss treatments for and prevention of the illness. Authorities agreed to continue monitoring the situation and issue early warnings through multiple channels to prevent further spreading, according to China's National Health Commission. Michelle Del Rey is a trending news reporter at USA TODAY. Contact her at mdelrey@ This article originally appeared on USA TODAY: Chikungunya virus cases reported in China prompt CDC travel notice Solve the daily Crossword


USA Today
26 minutes ago
- USA Today
CDC warns travelers about chikungunya cases in China as global infections hit 240,000
U.S. health officials are cautioning travelers about a mosquito-borne illness being transmitted in parts of Asia, South America, Africa and the Indian Ocean. Across the globe, the chikungunya virus has sparked 240,000 cases and 90 deaths in 2025, according to the European Centre for Disease Prevention and Control. The virus, which is infecting people through bites from Aedes mosquitoes, has been spreading in China's Guangdong province this summer. Health officials reported the area has seen over 7,000 confirmed cases since June. The U.S. Centers for Disease Control and Prevention (CDC) this month issued a travel notice for the Guangdon province in China, encouraging travelers to practice enhanced precautions. The agency issued the same notices for other countries where outbreaks have been reported, including Bolivia, Kenya, Madagascar, Mauritius, Mayotte, Réunion, Somalia and Sri Lanka. The CDC is also asking U.S. residents to exercise caution when visiting the following countries, which have not yet reported an outbreak but are at elevated risk of exposure: Brazil, Colombia, Mexico, India, Pakistan, Philippines, Thailand and Nigeria. According to the World Health Organization (WHO), 5.6 billion people are at risk of arboviral diseases such as chikungunya. Other widespread arboviruses impacting humans include dengue, Zika and yellow fever. What are the symptoms of chikungunya? Symptoms of the disease include fever, joint pain and swelling, headache, muscle pain and rash, according to the CDC. How long does infection last? The illness typically lasts between two to 12 days after infection. Some patients can experience extreme symptoms and the virus can be fatal. Elderly people, newborns and individuals with underlying medical conditions are at higher risk of medical intervention. Severe complications, including cardiovascular, neurological and multiorgan involvement, may require intensive medical care, according to the WHO. However, more than half of patients will experience symptoms commonly associated with a fever. What treatments are available? There are no known antiviral treatments for the illness. Medications can be used to manage pain and fever. Two chikungunya vaccines have received regulatory approval but are not widely available. In May, federal officials recommended pausing a vaccine in the United States after reports of serious adverse events. The illness was first discovered in Tanzania in 1952, with outbreaks being reported in Africa and Asia, according to the WHO. Since then, the virus has been transmitted to 119 countries. Last year, more than 620,000 and 213 deaths were reported globally, according to the European Centre for Disease Prevention and Control. In what was then dubbed the largest documented outbreak of chikungunya, an estimated several hundred thousand people were affected by "explosive" outbreaks of the virus in the Indian Ocean islands and India, according to a 2008 study. It's estimated that about 60 percent of regional populations were exposed. CDC issues travel notice for Americans The CDC issued a travel warning on Friday, Aug. 1, advising U.S. residents to take enhanced precautions when traveling to China. Most of the country's cases have been reported in the city of Foshan. Last month, Chinese officials held a national conference to discuss treatments for and prevention of the illness. Authorities agreed to continue monitoring the situation and issue early warnings through multiple channels to prevent further spreading, according to China's National Health Commission. Michelle Del Rey is a trending news reporter at USA TODAY. Contact her at mdelrey@
Yahoo
an hour ago
- Yahoo
Louisville boy makes medical history as first patient in US with new cochlear implant
DuJuan Broadus couldn't believe how loud the birds outside his bedroom window sounded. The buzzing of the cicadas near his grandmother's home in Georgetown was almost overwhelming. Having unknowingly lived with profound hearing loss for years, the world sounded so much more colorful than the Louisville native ever imagined. In December, DuJuan, now 11, went from having 'the hearing of a World War II veteran,' as one doctor put it, to becoming the first patient in the United States to receive a MED-EL FLEX34 cochlear implant. This new technology is the longest implant on the market and is designed for people, like DuJuan, who have an unusually large cochlea, which is the part of the ear that converts sound vibrations into signals the brain interprets as sound. If doctors had used a shorter model, DuJuan's hearing would have improved, but he wouldn't necessarily have access to such a dynamic range of frequencies, said Dr. Nathan Cass, a UK HealthCare otology and neurotology specialist, who implanted the FLEX34 in DuJuan's ear in December 2024. Specifically, lower, deeper sounds are limited, Cass said. If the electrode can't reach to the end of the patient's cochlea, they'll likely hear voices at a higher pitch. 'They'll say at their (cochlear implant) activation that voices sound kind of like Mickey Mouse,' Cass said. 'But one of the things that this new technology is aiming to try to help is to try to get people to get things to sound more natural.' With the help of the FLEX34, DuJuan now hears the world, and all the background noise that comes with it, at a completely different level. For the past eight months or so, it's been a daily adventure for him to learn and put names to sounds and background noises that his brain had never registered before. 'A lot of times it was really difficult, but I got used to it,' DuJuan told the Courier Journal. 'Now I can tell that the bird is a bird. I can tell a cricket is a cricket. I can tell a motorcycle is a motorcycle.' 'I didn't even know I had hearing loss' The journey to hearing and understanding what the world sounded like started well before DuJuan ended up at UK HealthCare. When DuJuan was about three years old, his parents noticed a speech impediment. His mother has a clear memory of him pointing to a motorcycle as a child, but pronouncing the word for it similar to the name 'Michael.' One of the first lines of intervention with speech is a hearing test. Studies have shown that about one to five children in about every 1,000 has hearing loss, according to the Centers for Disease Control and Prevention. More: Confused about the COVID-19 booster? Here's what children, pregnant women in Kentucky need to know DuJuan passed that first hearing test, and from there, his parents enrolled him in speech therapy. Over time, his speech improved, and he graduated from speech therapy in the third grade. But something still didn't seem right. His grades were strong in reading and math, but his fourth-grade teacher had concerns about how he responded when she spoke to him. She wasn't sure if he didn't understand the question or if he couldn't hear what she was asking. So Jefferson County Public Schools tested him for hearing loss, and this time he failed — dynamically. He was just 10 years old at the time, and was already in severe and profound stages of hearing loss. No one had noticed up until this point, though, because DuJuan is an incredibly bright and resilient child. Without knowing it, DuJuan had taught himself to read lips. He'd become so good at it over the years, that when his mother, Letisha Broadus, spoke to him in the car, he knew to crane his neck up so that he could see her lips moving in the rearview mirror. He thought that this was something that everyone needed to do. 'I didn't even know I had hearing loss at first,' he said. 'Once I knew, I asked my mom 'what is even hearing loss?'' Heartbroken for her son but also determined, Letisha tried to find an ear, nose and throat specialist in Louisville to help. The waitlists locally were months long, so doctors referred her to UK HealthCare's Ear, Nose and Throat Clinic in Lexington, which was ranked No. 37 in the nation by US News and World Report in 2024 for that specialty. The 70-mile trip to the doctors was worth it, if they could schedule a surgery for an implant sooner. In the meantime, DuJuan used a hearing aid, which typically helps patients with low or moderate hearing loss. The day they turned it on in March 2024 was unforgettable for the whole family. 'There were a lot of tears, and a lot of emotions because he could hear things for the first time,' Letisha remembered. When the doctor stapled something to his file, DuJuan's ears caught the quick, snap-like click a stapler makes for the first time, ever. 'Wow,' he told his mom. 'That's what that sounds like.' He had so many things to relearn. 'I wasn't able to stop smiling that day' On the day the Broaduses traveled to Lexington in December 2024 for the cochlear implant surgery, DuJuan was a little nervous, of course, but also excited for what else the implant might help him hear. There are only three companies in the world that manufacture cochlear implants. DuJuan and his parents selected MED-EL, which had released the longest implant currently on the market in 2023. The Food and Drug Administration approved it the July before DuJuan's surgery. DuJuan's cochlea was 38 millimeters long, and he's in the 5-7% of the largest cochleas in the country. It's rare enough that in the eight months that have followed since his surgery, Cass has only implanted one other FLEX34 on a patient. More: Their son died by suicide. Now this Louisville couple is helping other young adults The difference in those extra millimeters, though, is crucial for patients like DuJuan. The cochlea has two fluid-filled chambers lined with tiny hairs. When a sound occurs, it vibrates the fluid in the cochlea. Those impulses are translated into electrical signals that the brain interprets as sound. The farther the implant can reach into the chamber, the more natural the sound becomes in the brain. 'The vast number of sensory cells we have there allows for some of the richness of the sounds that we can understand, and the dynamic range of the frequencies is very large,' Cass explained. When they turned the implant on in the weeks that followed the surgery, DuJuan couldn't wait to hear the world the same way everyone else does. "I wasn't able to stop smiling that day," he remembers. DuJuan is a big fan of music. The hearing aid kept him from having to listen to it on full blast, but now the voices in the songs are clearer. With a shorter implant, the rap music he enjoys might sound like Mickey Mouse is trying to take cues from 50 Cent or Kendrick Lamar. The FLEX34 helps him hear music as everyone else does. Now he has access to lower, bass notes. More: 300 people in line? How hard-to-find bourbons made Buffalo Trace Distillery a cult favorite And that's important, because DuJuan has big plans to join the choir when he starts the sixth grade at Western Middle School for the Arts this school year. He's always been a musically inclined child. When DuJuan was a baby, his mother would sing little songs to him, and he'd somehow managed to reply with the same, proper note. And while he'll have to wait until he's older before his voice lowers enough to hit any bass notes himself — in the meantime, he certainly hears them more on tune than he ever has before. More: What is a cochlear implant? Learn more about device Reach features columnist Maggie Menderski at mmenderski@ Want to learn more? To learn more about cochlear implants, hearing loss, the FLEX34 and other electrodes available for hearing loss patients, visit This article originally appeared on Louisville Courier Journal: Louisville boy first patient in US with med-el-flex34 cochlear implant Solve the daily Crossword